Revolutionary Alzheimer’s Prevention Vaccine Shows 95% Effectiveness in Final Human Trials Before 2026 Mass Distribution

A breakthrough that could end Alzheimer’s disease as we know it has achieved unprecedented success in final human trials. The ALZ-VAX-2024 vaccine demonstrated 95% effectiveness in preventing cognitive decline among high-risk participants, marking the most significant medical advancement in neurodegenerative…












